glp-1 stopping Tapering Medications and Why Abrupt Raises Rebound Risk – STAAR LABS When you stop GLP-1 medications,

Following receptor-ligand interaction, the signal is transmitted via the Disheveled (Dvl) protein, which modulates the activity of several key regulators, including axis inhibition protein (Axin), adenomatous polyposis coli (APC), and glycogen synthase kinase-3 (GSK-3) [145]

For example, the Wegovy (semaglutide) prescribing information and Zepbound (tirzepatide) prescribing information describe stepwise start low and go slow titration to a maintenance dose that was tested in clinical trials and approved by regulators.[3,4] A microdose schedule is different and always off-label

Image Credit: MillaF / Shutterstock Obesity is associated with several complications, such as hypertension, diabetes, osteoarthritis, cancer, cardiovascular death, and premature death

However, additional research is necessary to ensure these findings are reproducible, and the durability of fasting-induced weight loss without ongoing therapeutic support remains uncertain